首页> 外文OA文献 >Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.

【2h】

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.

机译：乳腺癌中的表皮生长因子受体。与非恶性乳房组织的比较。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Epidermal growth factor receptors were measured using a radioligand binding assay in membrane preparations from 67 cancer and 25 non-malignant tissues. The binding characteristics of EGFr were similar in tumour and normal breast membranes. The concentrations were significantly higher in non-malignant tissue than in cancer. EGFr concentrations were directly correlated with steroid receptors in non-malignant tissue, whereas in cancer an inverse correlation between EGFr and steroid receptors was found.

机译：使用放射性配体结合测定法在来自67个癌症和25个非恶性组织的膜制剂中测量了表皮生长因子受体。 EGFr的结合特征在肿瘤和正常乳腺膜中相似。非恶性组织中的浓度显着高于癌症中的浓度。在非恶性组织中，EGFr的浓度与类固醇受体直接相关，而在癌症中，EGFr与类固醇受体之间呈负相关。

著录项

作者
Dittadi, R.; Donisi, P. M.; Brazzale, A.; Cappellozza, L.; Bruscagnin, G.; Gion, M.;
展开▼
作者单位

展开▼
年度 1993
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue [J] . R Dittadi, PM Donisi, A Brazzale, British Journal of Cancer . 1993,第1期

机译：乳腺癌中的表皮生长因子受体。与非恶性乳房组织的比较
2. Human epidermal growth factor receptor 2 status in breast cancer: A comparison between borderline positive human epidermal growth factor receptor 2 and strongly positive human epidermal growth factor receptor 2 tumors [J] . Joanna Huszno, Elzbieta Nowara Clinical Cancer Investigation Journal . 2015,第3期

机译：人表皮生长因子受体2在乳腺癌中的状态：临界阳性人表皮生长因子受体2与强阳性人表皮生长因子受体2肿瘤的比较
3. Estrogen receptor and receptor tyrosine kinase signaling: use of combinatorial hormone and epidermal growth factor receptor/human epidermal growth factor receptor 2-targeted therapies for breast cancer. [J] . Daniel J Zabransky, Ben Ho Park Journal of Clinical Oncology . 2014,第10期

机译：雌激素受体和酪氨酸激酶受体信号传导：组合激素和表皮生长因子受体/人表皮生长因子受体2靶向治疗乳腺癌的用途。
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. Combating resistance to epidermal growth factor receptor inhibitors in triple negative breast cancer. [D] . Madden, Julie M. 2014

机译：在三阴性乳腺癌中对抗表皮生长因子受体抑制剂的耐药性。
6. Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue. [O] . R. Dittadi, P. M. Donisi, A. Brazzale, 1993

机译：乳腺癌中的表皮生长因子受体。与非恶性乳房组织的比较。
7. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. [O] . Dihge, Looket, Bendahl, Pär-Ola, Grabau, Dorthe, 2008

机译：表皮生长因子受体（EGFR）和雌激素受体调节剂在乳腺癌（aIB1）中扩增，用于预测乳腺癌中辅助他莫昔芬后的临床结果。

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.

摘要

著录项

相似文献

相关主题

期刊订阅